Browse result page of CPPsite 2.0
The total number entries retrieved from this search are 1753| ID | PEPTIDE SEQUENCE | PEPTIDE NAME | LENGTH | CHIRALITY | LINEAR/CYCLIC | SOURCE | CATEGORY | N TERMINAL MODIFICATION | C TERMINAL MODIFICATION | CHEMICAL MODIFICATION | CARGO | PUBMED ID |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2001 | rrrrrrrrrcqcrrkn | R9-GO-203 | 16 | D | Linear | Synthetic | Cationic | Free | Free | NA | Small molecule drug (Taxol and doxorubicin) | 23114713 |
| 2002 | RRRRRRRGGIYLATALAKWALKQGF | P7-4 | 25 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore [DiSC3(5)] and peptide P7-27 | 23262194 |
| 2003 | IYLATALAKWALKQGFGGRRRRRRR | P7-5 | 25 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore [DiSC3(5)] and peptide P7-27 | 23262194 |
| 2004 | RRRRRRRGGIYLATALAKWALKQ | P7-6 | 23 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore [DiSC3(5)] and peptide P7-26 | 23262194 |
| 2005 | IYLATALAKWALKQGGRRRRRRR | P7-7 | 23 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore [DiSC3(5)] and peptide P7-26 | 23262194 |
| 2006 | RRRRRRRGGKLAKLAKKLAKLAK | R7-KLA | 23 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore [DiSC3(5)] | 23262194 |
| 2007 | KLAKLAKKLAKLAKGGRRRRRRR | KLA-R7 | 23 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore [DiSC3(5)] | 23262194 |
| 2008 | RWRWRWRW | (RW)4 | 8 | L | Linear | Synthetic | Cationic | Free | Free | Drug conjugated with peptide through linker | Small molecule drug (Doxorubicin) | 23301519 |
| 2010 | YGRKKRRQRRR | Tat-AIE dots | 11 | L | Linear | Protein derived | Amphipathic | Free | Free | NA | TPETPAFN and TPAFN | 23359649 |
| 2011 | KKALLAHALHLLALLALHLAHALKKA | LAH4-L1 | 26 | L | Linear | Synthetic | Amphipathic | Free | Free | NA | Nucleic acid (siRNA) | 23436406 |
| 2012 | RRRRRRRR | R9-GFP | 8 | L | Linear | Synthetic | Cationic | Free | Free | NA | Protein (eGFP) | 23497160 |
| 2013 | GALFLGFLGAAGSTMGAWSQPKSKRKV | MPGNLS | 27 | L | Linear | Synthetic | NA | Acetylation | Cysteamide group | NA | Nucleic acid (siRNA) | 23036951 |
| 2014 | GLWRALWRLLRSLWRLLWRA | CADY | 20 | L | Linear | Synthetic | Amphipathic | Acetylation | Cysteamide group | NA | Nucleic acid (siRNA) | 23036951 |
| 2015 | KAFAKLAARLYRKALARQLGVAA | KAFAK | 23 | L | Linear | Synthetic | NA | Free | Free | NA | Fluorophore (FITC) | 23041412 |
| 2016 | GSRVQIRCRFRNSTR | HSV-1 glycoprotein C gene (gC)--Crystallins | 15 | L | Linear | Synthetic | NA | Free | Free | NA | Protein (Human B-Crystallin) | 23150610 |
| 2017 | GRKKRRQRRRPQ | HIV-1 TAT peptide--Crystallins | 12 | L | Linear | Protein derived | NA | Free | Free | NA | Protein (Human B-Crystallin) | 23150610 |
| 2018 | CRNGRGPDC | iNGR | 9 | L | Linear | Synthetic | NA | Free | Free | NA | Small molecule drug (Doxorubicin) and Fluorophore (FAM) | 23151901 |
| 2019 | CNGRC | NGR | 5 | L | Linear | Synthetic | NA | Free | Free | NA | Small molecule drug (Doxorubicin) and Fluorophore (FAM) | 23151901 |
| 2020 | CRGDC | RGD | 5 | L | Linear | Synthetic | NA | Free | Free | NA | Small molecule drug (Doxorubicin) and Fluorophore (FAM) | 23151901 |
| 2021 | CRGDKGDPC | iRGD | 9 | L | Linear | Synthetic | NA | Free | Free | NA | Small molecule drug (Doxorubicin) and Fluorophore (FAM) | 23151901 |
| 2022 | NYRWRCKNQN | ECP(32-41) | 10 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC), Protein (eGFP) and Peptide (KLA) | 23469189 |
| 2023 | NYQRRCKNQN | EDN(32-41) | 10 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
| 2024 | NYQWRCKNQN | ECP(32-41)R3Q | 10 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
| 2025 | NYRRRCKNQN | ECP(32-41)W4R | 10 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
| 2026 | YRWRCKNQN | ECP(33-41) | 9 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
| 2027 | NYRWRCKNQ | ECP(32-40) | 9 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
| 2028 | YRWRCKNQ | ECP(33-40) | 8 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
| 2029 | NYRWRCKN | ECP(32-39) | 8 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
| 2030 | RWRCKNQN | ECP(34-41) | 8 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
| 2031 | NYRWRCK | ECP(32-38) | 7 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
| 2032 | GRKKRRQRRRP | TAT(47-57) | 11 | L | Linear | Protein derived | Amphipathic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
| 2033 | KLAKLAKKLAKLAK | KLA | 14 | L | Linear | Synthetic | Amphipathic | Free | Free | NA | Fluorophore (FITC) | 23469189 |
| 2034 | KLAKLAKKLAKLAKGRKKRRQRRRP | KLA-TAT(47-57) | 25 | L | Linear | Chimeric | Cationic | Free | Free | NA | Peptide (KLA) | 23469189 |
| 2035 | KLAKLAKKLAKLAKNYRWRCKNQN | KLA-ECP(32-41) | 24 | L | Linear | Chimeric | Cationic | Free | Free | NA | Peptide (KLA) | 23469189 |
| 2036 | AGYLLGOINLKALAALAKKIL | NF51 | 21 | Modified | Linear | Synthetic | Amphipathic | Stearylation | Amidation | O, Ornithine | Nucleic acid (Plasmid DNA, SCO and siRNA) | 23357356 |
| 2037 | AGYLLGKINLKALAALAKKIL | NF53 | 21 | Modified | Linear | Synthetic | Amphipathic | Stearylation | Amidation | ε-NH2 group of Lys7 for subsequent synthesis | Nucleic acid (Plasmid DNA, SCO and siRNA) | 23357356 |
| 2038 | AGYLLGKINLKALAALAKKIL | NF61 | 21 | Modified | Linear | Synthetic | Amphipathic | Stearylation | Amidation | α-NH2 group of Lys7 for subsequent synthesis | Nucleic acid (Plasmid DNA, SCO and siRNA) | 23357356 |
| 2039 | LLIILRRRIRKQAHAHSK | FAM-pVEC | 18 | L | Linear | Protein derived | NA | Conjugation with 5(6)-Carboxyfluorescein | Amidation | NA | Fluorophore [5(6)-carboxyfluorescein (FAM)] | 23350661 |
| 2040 | NHQQQNPHQPPM | FAM-gHo | 12 | L | Linear | Synthetic | NA | Conjugation with 5(6)-Carboxyfluorescein | Amidation | NA | Fluorophore [5(6)-carboxyfluorescein (FAM)] | 23350661 |
| 2041 | LLIILRRRIRKQAHAHSKNHQQQNPHQPPM | FAM-pVEC-gHo (FAM- gHoPe2) | 30 | L | Linear | Chimeric | NA | Conjugation with 5(6)-Carboxyfluorescein | Amidation | NA | Fluorophore [5(6)-carboxyfluorescein (FAM)] | 23350661 |
| 2042 | NHQQQNPHQPPMLLIILRRRIRKQAHAHSK | FAM-gHo-pVEC (FAM- gHoPe3) | 30 | L | Linear | Synthetic | NA | Conjugation with 5(6)-Carboxyfluorescein | Amidation | NA | Fluorophore [5(6)-carboxyfluorescein (FAM)] | 23350661 |
| 2043 | CLLIILRRRIRKQAHAHSKNHQQQNPHQPPM | Dox-pVEC-gHo (Dox- gHoPe2) | 31 | L | Linear | Synthetic | NA | Succinimidyl-4-(N-mal-eimidomethyl) cyclohexane-1-carboxylate (SMCC) | Amidation | NA | Small molecule drug (Doxorubicin) | 23350661 |
| 2044 | RKKRRQRRRGC | Tat-Cys | 11 | L | Linear | Protein derived | Cationic | Free | Amidation | NA | Fluorophore (TMR-5(6)C2- maleimide) | 23322746 |
| 2045 | RPARPAR | PA 1 | 7 | L | Linear | Synthetic | Amphipathic | Free | Free | NA | Fluorophore (Rhodamine) | 23349939 |
| 2046 | RPARPAR | PA 2 | 7 | L | Linear | Synthetic | Amphipathic | Di-palmitilysation | Free | NA | Fluorophore (Rhodamine) | 23349939 |
| 2047 | RPARPAR | PA 3 | 7 | L | Linear | Synthetic | Amphipathic | Di-palmitilysation | Amidation | NA | Fluorophore (Rhodamine) | 23349939 |
| 2048 | RPARPAR | PA 4 | 7 | L | Linear | Synthetic | Amphipathic | Free | Free | NA | DSP-PEG2000 and Fluorophore (Rhodamine) | 23349939 |
| 2049 | RPARPAR | PA 5 | 7 | L | Linear | Synthetic | Amphipathic | Free | Amidation | NA | DSP-PEG2000 and Fluorophore (Rhodamine) | 23349939 |
| 2050 | RPARPAR | PA 8 | 7 | L | Linear | Synthetic | Amphipathic | Di-palmitilysation | Free | NA | Fluorophore (Oregon514 dye) | 23349939 |
| 2051 | RKKWFW | PAF26 | 6 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore (TMR) | 23349973 |